Residency · Residency · Otolaryngology

Otosclerosis: Diagnosis and Stapedectomy

Overview

Otosclerosis is a primary bone dyscrasia of the otic capsule characterized by abnormal bone remodeling, leading to fixation of the stapes footplate and progressive conductive hearing loss. It is the most common cause of conductive hearing loss in adults with a normal tympanic membrane.

Epidemiology

Prevalence: clinical otosclerosis in ~0.3-0.5% of the population; histologic otosclerosis in up to 10% at autopsy. Predominantly affects Caucasians; rare in African and Asian populations. Female predominance (2:1); exacerbated by pregnancy (estrogen effect). Typical onset in 20s-30s, Bilateral in 70-80% of cases, Autosomal dominant with incomplete penetrance (~25-40%).

Pathophysiology

Bone Remodeling

Normal otic capsule bone is uniquely resistant to remodeling (endochondral bone). In otosclerosis, foci of abnormal bone resorption and new spongy bone deposition occur. Active (otospongiotic) phase: vascular, spongy bone with osteoclastic activity. Inactive (otosclerotic) phase: dense sclerotic bone. Most common site: fissula ante fenestram (anterior to the oval window) -- present in 96% of cases.

Stapes Fixation

Otosclerotic focus extends to involve the stapes footplate, Progressive fixation of the footplate in the oval window, Results in conductive hearing loss.

Cochlear Otosclerosis

Otosclerotic foci involving the otic capsule around the cochlea. Can cause sensorineural hearing loss (damage to spiral ligament, stria vascularis, or direct cochlear endosteum involvement). Release of cytokines and enzymes into the perilymph. "Far-advanced otosclerosis": severe mixed hearing loss.

Clinical Presentation

Progressive hearing loss (usually unilateral initially, eventually bilateral). Onset in 2nd-4th decade, Often noticed during pregnancy (hormonal acceleration). Paradoxical improvement in noisy environments (paracusis of Willis) -- the speaker raises their voice in noise, overcoming the conductive loss. Tinnitus (present in ~75%), No otorrhea, no pain, Family history in ~50%.

Examination

Normal tympanic membrane. Schwartze sign: reddish hue on the promontory seen through an intact TM (active otospongiosis with increased vascularity); uncommon but pathognomonic. Weber lateralizes to the affected (worse) ear, Rinne negative in the affected ear (BC > AC), Normal pneumatic otoscopy and tympanometry.

Audiometric Findings

Conductive hearing loss: air-bone gap, typically low-frequency predominant initially. Carhart notch: artifactual dip in bone conduction at 2000 Hz (due to loss of inertial component of bone conduction from stapes fixation); disappears after successful surgery. Progressive air-bone gap; eventually bone conduction may decline (mixed loss). Speech discrimination typically excellent until advanced disease. Tympanometry: Type As (shallow compliance, low peak) with normal middle ear pressure; absent acoustic reflexes.

Imaging

CT temporal bone (high resolution): not required for diagnosis but helpful for surgical planning. Lucent halo around the cochlea ("double ring" or "halo sign") = cochlear otosclerosis. Thickened stapes footplate. Fenestral otosclerosis may be subtle or not visible. Rules out other causes of CHL (superior semicircular canal dehiscence, ossicular anomalies).

Differential Diagnosis

Superior semicircular canal dehiscence (third window lesion -- VEMP testing, CT). Ossicular fixation (congenital, tympanosclerosis), Ossicular discontinuity, Middle ear mass (glomus tympanicum), Paget disease of the temporal bone. Osteogenesis imperfecta (van der Hoeve syndrome -- blue sclerae, otosclerosis, brittle bones).

Management

Conservative

Hearing aids: appropriate for patients who decline surgery or are not surgical candidates. Observation with serial audiograms for mild cases.

Medical Therapy

Sodium fluoride: theoretical role in stabilizing otosclerotic bone (inhibits osteoclasts). Evidence is limited and controversial. Not widely used currently. May be considered for cochlear otosclerosis or rapidly progressive SNHL component.

Surgical Treatment: Stapedectomy / Stapedotomy

Indications

Air-bone gap >= 15-20 dB with conductive hearing loss, Good speech discrimination, Negative Rinne test, Failed or declined hearing aid use. Operate on the worse-hearing ear first; if bilateral, wait 6-12 months before second ear.

Contraindications

Only hearing ear (relative -- very experienced surgeons may proceed). Active otitis media or externa. Poor general health / cannot tolerate local or general anesthesia. Meniere disease or endolymphatic hydrops (relative), Occupational risk (pilot, diver) -- relative.

Stapedectomy vs. Stapedotomy

Stapedectomy: complete removal of the stapes footplate; prosthesis placed over an opening covered by tissue graft (vein, fascia). Stapedotomy: small fenestra (0.6-0.8 mm) created in the footplate with laser or microdrill; piston prosthesis inserted -- preferred modern technique. Stapedotomy advantages: smaller opening reduces risk of perilymph fistula, floating footplate, and SNHL.

Surgical Technique (Stapedotomy)

Transcanal approach; elevate tympanomeatal flap posteriorly. Curette the scutum (posterosuperior canal wall) for exposure (atticotomy). Confirm stapes fixation by palpation. Divide the incudostapedial joint. Cut the stapedius tendon. Fracture and remove the stapes superstructure (crura). Create a small fenestra in the footplate (laser: CO2 or KTP; or microdrill). Measure distance from incus to footplate. Place prosthesis (typically Teflon piston or titanium) -- crimped onto the long process of the incus, piston inserted into the fenestra. Test hearing with tuning fork. Replace tympanomeatal flap.

Prosthesis Options

Teflon/fluoroplastic piston (most common), Titanium prosthesis, Nitinol (shape-memory) self-crimping prosthesis, Piston diameter typically 0.4-0.6 mm; length ~4.0-4.5 mm.

Outcomes

Successful closure of air-bone gap to within 10 dB in 90-95% of cases. SNHL risk: 1-2%. Complete hearing loss risk: <1%. Revision surgery success rate: 50-70%.

Complications

Sensorineural hearing loss (1-2%), Vertigo (transient in most; persistent in <1%), Tinnitus (new or worsened). Taste disturbance (chorda tympani manipulation) -- 10-30%, usually temporary. Perilymph fistula (post-stapedotomy leak), Prosthesis displacement or extrusion, Incus necrosis (long process). Facial nerve injury (rare; dehiscent facial nerve may overlie the oval window). Dead ear (<1%). Reparative granuloma: delayed SNHL 1-3 weeks postop; treated with steroids.

<image>Audiogram showing typical otosclerosis findings: conductive hearing loss with air-bone gap predominantly at low frequencies, Carhart notch (artifactual bone conduction dip) at 2000 Hz, and excellent speech discrimination scores. Labeled audiometric chart with air conduction, bone conduction, and speech recognition thresholds.</image>

<image>Surgical view of a right stapedotomy procedure showing the long process of the incus, the stapes footplate with a laser fenestra, and a Teflon piston prosthesis being placed through the fenestra and crimped onto the incus. The chorda tympani nerve is visible crossing the operative field. The promontory and round window niche are visible medially. Labeled intraoperative illustration.</image>

<image>Axial CT scan of the temporal bone demonstrating fenestral otosclerosis with thickening and lucency at the fissula ante fenestram (anterior to the oval window), and cochlear otosclerosis with a lucent halo surrounding the cochlea (double ring sign). Side-by-side comparison with a normal temporal bone CT. Labeled radiologic illustration.</image>

Clinical Pearls

Otosclerosis is the most common cause of progressive conductive hearing loss in a young adult with a normal TM. The Carhart notch at 2 kHz is artifactual and disappears after successful stapes surgery -- do not confuse it with true SNHL. Absent acoustic reflexes with a Type As tympanogram is the classic impedance pattern. Stapedotomy (small fenestra technique) has supplanted stapedectomy as the preferred surgical approach due to lower complication rates. Always check for an overhanging or dehiscent facial nerve before creating the fenestra. A reparative granuloma presenting as delayed SNHL 1-3 weeks postoperatively should be treated promptly with systemic steroids. Pregnancy can accelerate otosclerosis progression; counsel patients accordingly. If SNHL is present along with CHL, consider cochlear otosclerosis; sodium fluoride has been used but evidence is weak.

References

• Cureoglu S, Schachern PA, Ferlito A, et al. "Otosclerosis: etiopathogenesis and histopathology." Am J Otolaryngol. 2006;27(5):334-340.
• Quaranta N, Besozzi G, Fallacara RA, Quaranta A. "Air and bone conduction change after stapedotomy and partial stapedectomy for otosclerosis." Otolaryngol Head Neck Surg. 2005;133(1):116-120.
• Virk JS, Singh A, Lingam RK. "The role of imaging in the diagnosis and management of otosclerosis." Otol Neurotol. 2013;34(7):e55-e60.
• Vincent R, Sperling NM, Oates J, Jindal M. "Surgical findings and long-term hearing results in 3,050 stapedotomies for primary otosclerosis." Laryngoscope. 2006;116(10):1834-1841.

Read this lecture as Markdown